Natural history & registry data
Data management for natural history studies and patient registries that establish disease trajectory and inform endpoint selection ahead of interventional trials in ultra-rare populations.
Why rare disease sponsors choose us
Built for small, dispersed populations
Three ways an integrated Biometrics and Clinical Operations model changes how a rare disease program runs.
Biostatistics for small populations
Statistical designs suited to limited sample sizes, including Bayesian and adaptive approaches, external/historical control comparisons, and validation strategies for novel or surrogate endpoints.
Global recruitment coordination
Clinical Operations support for the multi-country site networks and patient advocacy coordination rare disease enrollment typically requires.
Common questions
Before you scope a rare disease study
Running a rare or orphan disease program?
Tell us your indication, population size, and endpoint status — we'll map a Biometrics and Clinical Operations model built for small-N evidence generation.